April - US: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: Today, my guest is April from the United States who takes LDN for multiple sclerosis. Thank you for joining us today, April. 

April: Thank you for giving me this opportunity. 

Annie - England: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Annemarie - England: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: I’d like to introduce Annemarie from England who has multiple sclerosis. Good morning Annemarie. 

Annemarie: Good Morning.

Anne - France: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: I'd like to introduce Anne from France who has Multiple Sclerosis. Welcome, Anne.

Anne (France): Thank you!

Anne - England: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: I'd like to introduce Anne from England who takes LDN for Multiple Sclerosis. Thank you for joining me Anne.

Anne: Okay.

Anne (2) - England: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: like to introduce Anne from England who takes LDN for multiple sclerosis. Good morning 

Anne (England): Good morning. 

Anna - England: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: This morning I'm joined by Anna from England who uses LDN for Secondary Progressive Multiple Sclerosis. Thank you for joining me, Anna.

Anna: That's a pleasure.

Anita - England: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: I'd like to introduce Anita from England. She takes LDM for multiple sclerosis. Good morning, Anita, 

Anita: Good morning. 

Angela - Wales: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: I'd like to introduce Angela from Wales who has Multiple Sclerosis. Welcome, Angela!

Angela: Hi, Linda!

Andy - Wales: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: I'd like to introduce Andy from Wales, and Andy has multiple sclerosis. Welcome, Andy. Could you tell us when were you diagnosed? 

Andy: Thank you. May 2005